Nathan Lekahal

Nathan Lekahal has extensive work experience in the field of business analytics and commercial planning. Nathan has held various roles in different companies, starting with Theravance Biopharma US, Inc. where they worked as an Associate Director from July 2019 to August 2020, then as a Director of Business Analytics & Insights from August 2020 to November 2021, followed by Director of Commercial Planning & Analytics from November 2021 to February 2023, and currently as a Senior Director of Business Analytics & Commercial Planning since February 2023.

Prior to Theravance Biopharma, Nathan worked at Gilead Sciences as a Senior Manager from June 2017 to November 2018, and then as an Associate Director of Managed Markets Analytics from November 2018 to July 2019.

Before joining Gilead Sciences, they worked at PwC as a Senior Associate in Health Industries Advisory from April 2014 to April 2015, and then as a Manager in the same department from April 2015 to June 2017.

Nathan's earlier work experience includes roles at PricewaterhouseCoopers as an Associate in Economics & Statistics from October 2009 to January 2011, at The George Washington University as a Statistics Instructor from August 2009 to January 2011, and at The University of Georgia as a Statistics Instructor from August 2008 to May 2009.

Nathan Lekahal obtained a Bachelor of Science degree in Mathematics-Statistics from Colorado State University in the years 2002 to 2007. Nathan then pursued a Master of Science degree in Statistics at The University of Georgia from 2007 to 2009. In addition to their formal education, Nathan also obtained additional certifications, including the Certified Professional Forecaster (CPF) from the Institute of Business Forecasting & Planning in 2021 and a certification in Pharmaceutical Management from Cornell University in 2019.